Sahm ScreenerSaudi Stock Screenerفلتر الأسهم السعودية
Home / Dr. Sulaiman Al Habib Medical Services Group / 2023 Annual Results

Dr. Sulaiman Al Habib Medical Services Group 2023 Annual Results

Revenue
SAR 9.51B
Net Profit
SAR 2.05B
EPS
SAR 5.85
Operating Cash Flow
SAR 3.24B

Dr. Sulaiman Al Habib Medical Services Group (4013) reported full year 2023 revenue of SAR 9.51B, up 70.9% from SAR 5.56B in 2022. Net profit came in at SAR 2.05B, up 23.9% year on year. Earnings per share were SAR 5.85. The company generated SAR 3.24B in operating cash flow. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Earnings Quality

Of every SAR 1.00 in reported net profit, SAR 1.59 arrived as operating cash flow — indicating Exceptional quality earnings with a cash conversion ratio of 1.59.

Key Financial Metrics

Metric20232022
RevenueSAR 9.51BSAR 5.56B
Net ProfitSAR 2.05BSAR 1.65B
Gross ProfitSAR 2.75B
Net Margin21.5%29.7%
ROE31.6%28.1%
EPSSAR 5.85
Total AssetsSAR 15.80BSAR 12.58B
Total EquitySAR 6.49BSAR 5.88B
Total LiabilitiesSAR 9.03B
Operating Cash FlowSAR 3.24B

Year on Year Comparison

Revenue increased by 70.9% compared to 2022. Net profit increased by 23.9%. Both revenue and profit grew — indicating expanding business.

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2024-02-20.